Based on scRNA-seq analysis and in vitro experiments, Aiko showed that high levels of IL-1β in TME may cooperate with IFN-γ to induce up-regulated expression of PD-L1 in tumor cells through activation of MAPK signaling, which in turn leads to resistance to tumor immunosuppression (13). The gene discussed is CD274; the disease is neoplasm.